Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Harvard Bioscience Inc

HBIO
Current price
0.38 USD -0.013 USD (-3.33%)
Last closed 0.40 USD
ISIN US4169061052
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 16 664 143 USD
Yield for 12 month -89.84 %
1Y
3Y
5Y
10Y
15Y
HBIO
21.11.2021 - 28.11.2021

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts. Address: 84 October Hill Road, Holliston, MA, United States, 01746

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

4.50 USD

P/E ratio

Dividend Yield

Current Year

+94 135 000 USD

Last Year

+112 250 000 USD

Current Quarter

+24 556 000 USD

Last Quarter

+21 970 000 USD

Current Year

+54 766 000 USD

Last Year

+66 071 000 USD

Current Quarter

+14 011 000 USD

Last Quarter

+12 765 000 USD

Key Figures HBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 2 441 000 USD
Operating Margin TTM 1.87 %
Price to Earnings
Return On Assets TTM -2.23 %
PEG Ratio 2.89
Return On Equity TTM -18.19 %
Wall Street Target Price 4.50 USD
Revenue TTM 94 135 000 USD
Book Value 1.44 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -12.80 %
Dividend Yield
Gross Profit TTM 54 809 000 USD
Earnings per share -0.28 USD
Diluted Eps TTM -0.28 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY -80.30 %
Profit Margin -13.18 %

Dividend Analytics HBIO

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History HBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1319:1000
Payout Ratio TTM
Last Split Date 04.11.2013

Stock Valuation HBIO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 14.93
Enterprise Value Revenue 0.61
Price Sales TTM 0.18
Enterprise Value EBITDA 179.26
Price Book MRQ 0.27

Financials HBIO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HBIO

For 52 weeks

0.36 USD 4.08 USD
50 Day MA 0.69 USD
Shares Short Prior Month 1 046 803
200 Day MA 2.03 USD
Short Ratio 2.88
Shares Short 1 048 777
Short Percent 2.56 %